Comorbidities in Chronic Spontaneous Urticaria: Integrating Disease Drivers and Systemic Consequences
International Journal of Molecular Sciences · 27.10.2026 · 27 (21) · 9615
DOI: 10.3390/ijms27219615 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.10.2026. Verfasst von Joo-Hee Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym Universi…. Hauptthemen laut MEDLINE: Chronic Urticaria, Urticaria. Die Arbeit nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Gyeonggi Research Institute.
Abstract (Originalsprache)
Chronic spontaneous urticaria (CSU) is a mast cell-driven inflammatory skin disorder traditionally considered self-limiting and non-life-threatening. However, accumulating evidence suggests that CSU is associated with multiple comorbidities, reflecting systemic immune and neuroinflammatory dysregulation. These comorbidities may act as both triggers and consequences of disease activity, forming a complex network centered on mast cell activation. Autoimmune diseases, particularly autoimmune thyroid disease, are strongly associated with CSU, especially in the type IIb autoimmune endotype. By contrast, type I autoallergic CSU is associated with immunoglobulin E (IgE) autoantibodies. Atopic diseases, neuroimmune interactions, and psychiatric conditions may further contribute to disease persistence through mechanisms involving IgE signaling and substance P-mediated mast cell activation via Mas-related G protein-coupled receptor X2. Metabolic and cardiovascular comorbidities have also been reported, with recent large-scale cohort studies strengthening the evidence for an association with cardiovascular risk, although causality remains unestablished. Associations with malignancy remain uncertain, whereas recent real-world studies suggest increased mortality among patients with CSU, potentially reflecting the underlying comorbidity burden rather than direct disease effects. Importantly, effective disease control may improve CSU outcomes and associated comorbidities. A comprehensive, mechanism-based approach that integrates comorbidity assessment into clinical management is essential for optimizing patient care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang 14068, Republic of Korea.
- Department of Pulmonology, Allergy and Critical Care Medicine, CHA Bundang Medical Center, CHA University, Seongnam 13496, Republic of Korea.
- Department of Allergy and Clinical Immunology, Ajou University School of Medicine, 164 WorldCup-ro, Yeongtong-gu, Suwon 16499, Republic of Korea.
ORCID-Profile: Mi-Ae Kim, Young-Min Ye
Förderung
- National Research Foundation of Korea
- Gyeonggi Research Institute
Zitieren
APA
Kim, J. H., Kim, M. A., & Ye, Y. M. (2026). Comorbidities in Chronic Spontaneous Urticaria: Integrating Disease Drivers and Systemic Consequences. International Journal of Molecular Sciences, 27(21), 9615. https://doi.org/10.3390/ijms27219615
Vancouver
Kim JH, Kim MA, Ye YM. Comorbidities in Chronic Spontaneous Urticaria: Integrating Disease Drivers and Systemic Consequences. International Journal of Molecular Sciences. 2026;27(21):9615. doi:10.3390/ijms27219615
BibTeX
@article{Kim2026,
author = {Kim, Joo-Hee and Kim, Mi-Ae and Ye, Young-Min},
title = {Comorbidities in Chronic Spontaneous Urticaria: Integrating Disease Drivers and Systemic Consequences},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {21},
pages = {9615},
doi = {10.3390/ijms27219615}
}
EUVIMED